Movatterモバイル変換


[0]ホーム

URL:


IL276627A - Compositions for diagnosis and treatment of coronavirus infections - Google Patents

Compositions for diagnosis and treatment of coronavirus infections

Info

Publication number
IL276627A
IL276627AIL276627AIL27662720AIL276627AIL 276627 AIL276627 AIL 276627AIL 276627 AIL276627 AIL 276627AIL 27662720 AIL27662720 AIL 27662720AIL 276627 AIL276627 AIL 276627A
Authority
IL
Israel
Prior art keywords
diagnosis
compositions
treatment
coronavirus infections
coronavirus
Prior art date
Application number
IL276627A
Other languages
Hebrew (he)
Inventor
FLEISHMAN Sarel
Diskin Ron
COHEN-DVASHI Hadas
Y Weinstein Jonathan
Original Assignee
Yeda Res & Dev
FLEISHMAN Sarel
Diskin Ron
Hadas Cohen Dvashi
Y Weinstein Jonathan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev, FLEISHMAN Sarel, Diskin Ron, Hadas Cohen Dvashi, Y Weinstein JonathanfiledCriticalYeda Res & Dev
Priority to IL276627ApriorityCriticalpatent/IL276627A/en
Priority to PCT/IL2021/050977prioritypatent/WO2022034588A1/en
Publication of IL276627ApublicationCriticalpatent/IL276627A/en

Links

Classifications

Landscapes

IL276627A2020-08-102020-08-10Compositions for diagnosis and treatment of coronavirus infectionsIL276627A (en)

Priority Applications (2)

Application NumberPriority DateFiling DateTitle
IL276627AIL276627A (en)2020-08-102020-08-10Compositions for diagnosis and treatment of coronavirus infections
PCT/IL2021/050977WO2022034588A1 (en)2020-08-102021-08-10Compositions for diagnosis and treatment of coronavirus infections

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
IL276627AIL276627A (en)2020-08-102020-08-10Compositions for diagnosis and treatment of coronavirus infections

Publications (1)

Publication NumberPublication Date
IL276627Atrue IL276627A (en)2022-03-01

Family

ID=80247809

Family Applications (1)

Application NumberTitlePriority DateFiling Date
IL276627AIL276627A (en)2020-08-102020-08-10Compositions for diagnosis and treatment of coronavirus infections

Country Status (2)

CountryLink
IL (1)IL276627A (en)
WO (1)WO2022034588A1 (en)

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
NL154600B (en)1971-02-101977-09-15Organon Nv METHOD FOR THE DETERMINATION AND DETERMINATION OF SPECIFIC BINDING PROTEINS AND THEIR CORRESPONDING BINDABLE SUBSTANCES.
NL154598B (en)1970-11-101977-09-15Organon Nv PROCEDURE FOR DETERMINING AND DETERMINING LOW MOLECULAR COMPOUNDS AND PROTEINS THAT CAN SPECIFICALLY BIND THESE COMPOUNDS AND TEST PACKAGING.
NL154599B (en)1970-12-281977-09-15Organon Nv PROCEDURE FOR DETERMINING AND DETERMINING SPECIFIC BINDING PROTEINS AND THEIR CORRESPONDING BINDABLE SUBSTANCES, AND TEST PACKAGING.
US3901654A (en)1971-06-211975-08-26Biological DevelopmentsReceptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en)1971-09-011974-12-10W DreyerImmunological reagent and radioimmuno assay
US3867517A (en)1971-12-211975-02-18Abbott LabDirect radioimmunoassay for antigens and their antibodies
NL171930C (en)1972-05-111983-06-01Akzo Nv METHOD FOR DETERMINING AND DETERMINING BITES AND TEST PACKAGING.
US3850578A (en)1973-03-121974-11-26H McconnellProcess for assaying for biologically active molecules
US3935074A (en)1973-12-171976-01-27Syva CompanyAntibody steric hindrance immunoassay with two antibodies
US3996345A (en)1974-08-121976-12-07Syva CompanyFluorescence quenching with immunological pairs in immunoassays
US4034074A (en)1974-09-191977-07-05The Board Of Trustees Of Leland Stanford Junior UniversityUniversal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en)1975-11-131976-10-05General Electric CompanyElectrophoretic method of detecting antigen-antibody reaction
US4098876A (en)1976-10-261978-07-04Corning Glass WorksReverse sandwich immunoassay
US4879219A (en)1980-09-191989-11-07General Hospital CorporationImmunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en)1984-04-121991-04-30The General Hospital CorporationMultiepitopic immunometric assay
US4666828A (en)1984-08-151987-05-19The General Hospital CorporationTest for Huntington's disease
US4683202A (en)1985-03-281987-07-28Cetus CorporationProcess for amplifying nucleic acid sequences
US4801531A (en)1985-04-171989-01-31Biotechnology Research Partners, Ltd.Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5272057A (en)1988-10-141993-12-21Georgetown UniversityMethod of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en)1989-08-251993-03-09Genetype AgIntron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5959177A (en)1989-10-271999-09-28The Scripps Research InstituteTransgenic plants expressing assembled secretory antibodies
US5281521A (en)1992-07-201994-01-25The Trustees Of The University Of PennsylvaniaModified avidin-biotin technique
WO1998033914A1 (en)1997-01-311998-08-06University Of RochesterChimeric antibody fusion proteins for the recruitment and stimulation of an antitumor immune response
US6777196B2 (en)1997-02-182004-08-17Genentech, Inc.Neurturin receptor
CN1261281A (en)1997-05-142000-07-26罗纳·布朗克罗尔药制品有限公司Peptide parathyroid hormone analogs
US6040498A (en)1998-08-112000-03-21North Caroline State UniversityGenetically engineered duckweed
KR100797667B1 (en)1999-10-042008-01-23메디카고 인코포레이티드 How to regulate transcription of foreign genes
US7125978B1 (en)1999-10-042006-10-24Medicago Inc.Promoter for regulating expression of foreign genes
EP2311962B1 (en)2002-03-292013-03-13XOMA Technology Ltd.Multigenic vectors plasmids and methods for increasing expression of recombinant polypeptides
EP2674495A1 (en)2012-06-142013-12-18SanofiCHO expression system
US20220002699A1 (en)*2020-03-072022-01-06Planet Biotechnology, Inc.ACE2-Fc FUSION PROTEINS FOR SARS-COV-2 MITIGATION
KR20220154796A (en)*2020-03-162022-11-22더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 Modified angiotensin-converting enzyme 2 (ACE2) and uses thereof
US20230203466A1 (en)*2020-04-032023-06-29Medgenome Inc.Ace2 receptor polymorphisms and varying susceptibility to sars-cov-2, methods for diagnosis and treatment

Also Published As

Publication numberPublication date
WO2022034588A1 (en)2022-02-17

Similar Documents

PublicationPublication DateTitle
ZA202208630B (en)Use of pharmaceutical composition for preventing and treating novel coronavirus pneumonia
IL308221A (en)Compositions and methods for the treatment of depression
EP4117630A4 (en)Treatment of coronavirus infection
EP4216961A4 (en)Compositions and methods for treatment of coronavirus infection
EP4135719A4 (en)Treatment of coronavirus infections
IL312583A (en)Composition for treatment and prevention of covid-19
GB202103578D0 (en)Prevention and treatment of infections including those caused by coronavirus
EP4121038A4 (en)Compositions and methods for the treatment of coronavirus infection and respiratory compromise
EP3946420A4 (en)Methods and compositions for treatment of coronavirus infection and associated coagulopathy
GB2595513B (en)Treatment of infections
EP4100029A4 (en)Compositions and methods of use thereof for treatment of mastitis
EP4041222A4 (en)Cannabidiol-enhanced probiotic compositions and uses thereof for treatment of infections
IL276627A (en)Compositions for diagnosis and treatment of coronavirus infections
ZA202210585B (en)Parapoxvirus for conditioning for and treatment of coronavirus infections
IL307872A (en)Novel compositions and methods for treating coronavirus infections
EP4232160A4 (en) COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF CORONAVIRUS
IL288415A (en)Compositions and methods for treatment of hemochromatosis
EP4132503A4 (en)Methods for treatment of coronavirus infections
HK40092915A (en)Compositions and methods for treatment of vaginal infections
HK40092897A (en)Methods and compositions for treatment and prevention of coronavirus infection
GB202013389D0 (en)Diagnosis and treatment of burkholderia infections
HK40105820A (en)Methods and compositions for treatment of disease
EP4304624A4 (en)Methods and compositions for treatment of disease
IL319307A (en)Compositions and methods for the prevention and treatment of orthopoxvirus infections
ZA202005856B (en)Treatment of infections

[8]ページ先頭

©2009-2025 Movatter.jp